RecallRadar

FDA Drug recall D-0094-2022

Acetaminophen Oral Suspension, 160 mg/5 mL, packaged in 5 mL per cup (NDC Individual cup: 68094-231-59), in a) 30-count case (NDC 30-count…

On 2021-11-17 the FDA classified a Class II recall of Acetaminophen Oral Suspension, 160 mg/5 mL, packaged in 5 mL per cup (NDC Individual cup: 68094-231-59), in a) 30-count case (NDC 30-count… by Precision Dose, citing cGMP Deviations: Product manufactured with contaminated raw ingredient.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0094-2022
ClassificationClass II
Statusterminated
Initiated2021-11-01
Published2021-11-17
Last updated2026-09-13 11:52 UTC
CompanyPrecision Dose
DistributionUS

Product

Acetaminophen Oral Suspension, 160 mg/5 mL, packaged in 5 mL per cup (NDC Individual cup: 68094-231-59), in a) 30-count case (NDC 30-count case: 68094-231-62), and b) 100-count case (NDC 100-count case: 68094-231-61), Hospital Use Only, Pkg. Precision Dose, Inc., S. Beloit, IL 61080.

Reason

cGMP Deviations: Product manufactured with contaminated raw ingredient.

Identifiers

ndc68094-231-59
ndc68094-231-62
ndc68094-231-61
ndc68094-231-01
ndc68094-231-58
ndc68094-330-59
ndc68094-330-62
ndc68094-330-61
ndc68094-030-59
ndc68094-030-62
code_infoLot#: 503670

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0094-2022%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.